[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].

Li, Jian

[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer]. [electronic resource] - Zhonghua zhong liu za zhi [Chinese journal of oncology] Mar 2008 - 225-7 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0253-3766


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Camptothecin--administration & dosage
Colonic Neoplasms--drug therapy
Disease Progression
Female
Fluorouracil--adverse effects
Follow-Up Studies
Humans
Irinotecan
Leucovorin--adverse effects
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neutropenia--chemically induced
Prospective Studies
Rectal Neoplasms--drug therapy
Remission Induction
Survival Rate
Vomiting--chemically induced
Young Adult